Circulating markers of endothelial function in cardiovascular disease

Joël Constans1, Claude Conri

  • 1Service de Médecine Interne et Médecine Vasculaire, Hôpital Saint-André, 1 rue Jean Burguet, 33075 Bordeaux And EA 3670, Université Victor Segalen-Bordeaux II, 146 rue Léo Saignat, 33000 Bordeaux, France. joel.constans@chu-bordeaux.fr

Insights

Measuring endothelial dysfunction is crucial for cardiovascular disease prevention. Soluble thrombomodulin and von Willebrand factor show promise as reliable biomarkers for identifying at-risk individuals.

Area of Science:

  • Cardiovascular Science
  • Biomarker Discovery

Background:

  • Endothelial dysfunction is central to cardiovascular disease development.
  • Accurate in vivo measurement is vital for primary prevention strategies.
  • Existing biomarkers like sICAM-1, sVCAM-1, and sE-selectin have limitations in specificity and application.

Purpose of the Study:

  • To evaluate the utility of various biological markers for assessing endothelial dysfunction.
  • To identify reliable biomarkers for predicting cardiovascular disease risk and guiding therapeutic intervention.

Main Methods:

  • Review and analysis of existing literature on endothelial dysfunction biomarkers.
  • Comparison of specificity and predictive value of soluble adhesion molecules, soluble thrombomodulin, and von Willebrand factor.

Main Results:

  • Soluble adhesion molecules (sICAM-1, sVCAM-1) lack specificity, being elevated in general inflammation.
  • sE-selectin is endothelium-specific but linked to coronary artery disease and diabetes risk.
  • Soluble thrombomodulin correlates with disease severity (coronary artery disease, stroke) and decreases with treatment.
  • Von Willebrand factor emerges as a superior biomarker, predicting ischemic heart disease and stroke risk.

Conclusions:

  • Von Willebrand factor is the most effective endothelial biomarker for predicting cardiovascular events.
  • Soluble thrombomodulin shows potential for assessing disease severity and treatment response.
  • Accurate endothelial dysfunction markers are essential for early intervention in cardiovascular disease prevention.